MedTrace Logo

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

NCT06702111 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-11-27

No results posted yet for this study

Summary

To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.

Conditions

  • Hematopoietic Stem Cell Transplant (HSCT)

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Harry HS Gill, MBBS, MD, FRCP, FRCPath · Department of Medicine, the University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06702111 on ClinicalTrials.gov